Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
9.20
+0.01 (0.11%)
At close: Jun 10, 2026, 4:00 PM EDT
9.24
+0.04 (0.43%)
After-hours: Jun 10, 2026, 4:00 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $829.62 million as of June 10, 2026. Its market cap has increased by 226.49% in one year.
Market Cap
829.62M
Enterprise Value
781.07M
1-Year Change
226.49%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $829.62M, an increase of 138.95%. That is a compound annual growth rate of 18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 836.83M | 98.27% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 880.06M |
| Olema Pharmaceuticals | 863.87M |
| Theravance Biopharma | 844.95M |
| Lexicon Pharmaceuticals | 843.97M |
| MeiraGTx Holdings | 832.56M |
| LB Pharmaceuticals | 827.75M |
| Arbutus Biopharma | 823.73M |
| Odyssey Therapeutics | 820.36M |